Trial intelligence / Profile preview

Propofol versus desflurane for surgical field quality in endoscopic endonasal transsphenoidal surgery

TCTR20230105002Phase 4Unknown

Sponsor
Chulalongkorn University
Start
Jun 2022
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol and desflurane in pituitary neoplasm (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Quality of surgical field. Status: unknown.

02

Drugs

propofoldesflurane
03

Conditions

pituitary neoplasm

Beyond the preview

Go deeper on TCTR20230105002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230105002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call